EE05581B1 - Aripiprasooli ravimlahus peroraalseks manustamiseks - Google Patents
Aripiprasooli ravimlahus peroraalseks manustamiseksInfo
- Publication number
- EE05581B1 EE05581B1 EEP200300523A EEP200300523A EE05581B1 EE 05581 B1 EE05581 B1 EE 05581B1 EE P200300523 A EEP200300523 A EE P200300523A EE P200300523 A EEP200300523 A EE P200300523A EE 05581 B1 EE05581 B1 EE 05581B1
- Authority
- EE
- Estonia
- Prior art keywords
- oral
- aripiprazole
- solution
- oral administration
- administration
- Prior art date
Links
- 229940072100 aripiprazole oral solution Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US28671801P | 2001-04-25 | 2001-04-25 | |
PCT/US2002/013048 WO2002085366A1 (en) | 2001-04-25 | 2002-04-24 | Aripiprazole oral solution |
Publications (2)
Publication Number | Publication Date |
---|---|
EE200300523A EE200300523A (et) | 2004-02-16 |
EE05581B1 true EE05581B1 (et) | 2012-10-15 |
Family
ID=23099862
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EEP200300523A EE05581B1 (et) | 2001-04-25 | 2002-04-24 | Aripiprasooli ravimlahus peroraalseks manustamiseks |
Country Status (37)
Country | Link |
---|---|
US (1) | US6977257B2 (hu) |
EP (2) | EP1381367B1 (hu) |
JP (1) | JP4401077B2 (hu) |
KR (1) | KR100909329B1 (hu) |
CN (1) | CN1512884B (hu) |
AR (1) | AR033168A1 (hu) |
AT (1) | ATE537831T1 (hu) |
AU (1) | AU2002254722B2 (hu) |
BG (1) | BG66177B1 (hu) |
BR (1) | BR0208986A (hu) |
CA (1) | CA2445276C (hu) |
CY (1) | CY1112606T1 (hu) |
CZ (1) | CZ306181B6 (hu) |
DK (1) | DK1381367T3 (hu) |
EE (1) | EE05581B1 (hu) |
ES (1) | ES2377855T3 (hu) |
GE (1) | GEP20053602B (hu) |
HK (2) | HK1058316A1 (hu) |
HR (1) | HRP20030870B1 (hu) |
HU (1) | HU230456B1 (hu) |
IL (2) | IL158202A0 (hu) |
IS (1) | IS2863B (hu) |
MX (1) | MXPA03009728A (hu) |
MY (1) | MY129350A (hu) |
NO (1) | NO324606B1 (hu) |
NZ (1) | NZ528550A (hu) |
PE (1) | PE20021086A1 (hu) |
PL (1) | PL206882B1 (hu) |
PT (1) | PT1381367E (hu) |
RS (1) | RS52082B (hu) |
RU (1) | RU2295960C2 (hu) |
SK (1) | SK287948B6 (hu) |
TW (1) | TWI337865B (hu) |
UA (1) | UA76144C2 (hu) |
UY (1) | UY27273A1 (hu) |
WO (1) | WO2002085366A1 (hu) |
ZA (1) | ZA200307797B (hu) |
Families Citing this family (55)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6770478B2 (en) * | 2000-02-10 | 2004-08-03 | The Regents Of The University Of California | Erythrocytic cells and method for preserving cells |
ATE428423T1 (de) * | 2002-08-20 | 2009-05-15 | Bristol Myers Squibb Co | Aripiprazol-komplex-formulierung und verfahren |
EP1680144B1 (en) * | 2003-10-08 | 2011-10-05 | Mallinckrodt LLC | Methylphenidate solution and associated methods of administration and production |
DK1675573T4 (da) * | 2003-10-23 | 2012-08-06 | Otsuka Pharma Co Ltd | Steril, injicerbr aripiprazol-formulering med kontrolleret frigivelse samt fremgangsmåde |
US20080234291A1 (en) * | 2004-01-21 | 2008-09-25 | Marc Karel Jozef Francois | Mitratapide Oral Solution |
US20070148100A1 (en) | 2005-09-15 | 2007-06-28 | Elan Pharma International, Limited | Nanoparticulate aripiprazole formulations |
EP1808164B2 (en) * | 2006-01-05 | 2018-07-04 | Teva Pharmaceutical Industries Ltd | Wet granulation method for preparing pharmaceutical compositions of aripiprazole |
US20070154545A1 (en) * | 2006-01-05 | 2007-07-05 | Julia Hrakovsky | Dry formulations of aripiprazole |
JP4892264B2 (ja) * | 2006-03-30 | 2012-03-07 | 高田製薬株式会社 | リスペリドン水性液剤 |
ATE523602T1 (de) | 2006-06-12 | 2011-09-15 | Hadasit Med Res Service | Mit durch antipsychotika induzierten extrapyramidalen symptomen assoziierte rgs2- genotypen |
GB0618879D0 (en) | 2006-09-26 | 2006-11-01 | Zysis Ltd | Pharmaceutical compositions |
TWI410255B (zh) * | 2007-07-31 | 2013-10-01 | Otsuka Pharma Co Ltd | 阿立哌唑(Aripiprazole)懸浮液及冷凍乾燥調配物之製法 |
WO2009042166A1 (en) * | 2007-09-25 | 2009-04-02 | Panacos Pharmaceuticals, Inc. | Liquid bevirimat dosage forms for oral administration |
GB2456183A (en) * | 2008-01-04 | 2009-07-08 | Gw Pharma Ltd | Anti-psychotic composition comprising cannabinoids and anti-psychotic medicament |
US8173621B2 (en) | 2008-06-11 | 2012-05-08 | Gilead Pharmasset Llc | Nucleoside cyclicphosphates |
CN102753563A (zh) | 2008-12-23 | 2012-10-24 | 吉利德制药有限责任公司 | 核苷类似物 |
WO2010075554A1 (en) | 2008-12-23 | 2010-07-01 | Pharmasset, Inc. | Synthesis of purine nucleosides |
PA8855601A1 (es) | 2008-12-23 | 2010-07-27 | Forformidatos de nucleósidos | |
TWI598358B (zh) | 2009-05-20 | 2017-09-11 | 基利法瑪席特有限責任公司 | 核苷磷醯胺 |
WO2010146872A1 (ja) * | 2009-06-19 | 2010-12-23 | 株式会社メドレックス | アリピプラゾールと有機酸を有効成分とする外用剤組成物 |
TR201000948A1 (tr) | 2010-02-09 | 2011-08-22 | Sanovel İlaç San.Ve Ti̇c.A.Ş. | Aripiprazol formülasyonları. |
JP6058528B2 (ja) | 2010-03-31 | 2017-01-11 | ギリアド ファーマセット エルエルシー | ヌクレオシドホスホルアミデート |
PL3290428T3 (pl) | 2010-03-31 | 2022-02-07 | Gilead Pharmasset Llc | Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu |
PL2609923T4 (pl) | 2010-03-31 | 2017-11-30 | Gilead Pharmasset Llc | Proces krystalizacji 2-(((s)-(perfluorofenoksy) (fenoksy)fosforylo)amino)propanianu (s)-izopropylu |
JP6069215B2 (ja) | 2010-11-30 | 2017-02-01 | ギリアド ファーマセット エルエルシー | 化合物 |
EP2685979B1 (en) | 2011-03-18 | 2016-08-24 | Alkermes Pharma Ireland Limited | Injectable pharmaceutical compositions comprising a water-insoluble anti-psychotic, sorbitan laurate and polysorbate 20 |
JO3410B1 (ar) * | 2011-06-07 | 2019-10-20 | Otsuka Pharma Co Ltd | تركيبة أريبيبرازول مجفف بالتبريد |
CN102846616B (zh) * | 2011-06-27 | 2015-05-06 | 上海中西制药有限公司 | 一种阿立哌唑制剂及其制备方法 |
CN102846543B (zh) * | 2011-06-27 | 2014-11-19 | 上海中西制药有限公司 | 一种阿立哌唑药物制剂及其制备方法 |
JO3190B1 (ar) * | 2011-10-19 | 2018-03-08 | Otsuka Pharma Co Ltd | محلول للتناول عن طريق الفم |
NZ630643A (en) | 2012-03-19 | 2017-08-25 | Alkermes Pharma Ireland Ltd | Pharmaceutical compositions comprising fatty acid esters |
AU2013235523B9 (en) | 2012-03-19 | 2018-01-04 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising glycerol esters |
CA2867137C (en) | 2012-03-19 | 2020-12-08 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions comprising aripiprazole prodrugs and benzyl alcohol |
JOP20200109A1 (ar) | 2012-04-23 | 2017-06-16 | Otsuka Pharma Co Ltd | مستحضر قابل للحقن |
JP5341282B1 (ja) * | 2012-06-29 | 2013-11-13 | 丸石製薬株式会社 | アリピプラゾールの経口医薬製剤 |
US20150174247A1 (en) | 2012-06-29 | 2015-06-25 | Maruishi Pharmaceutical Co., Ltd. | Oral pharmaceutical preparation of aripiprazole |
KR101571670B1 (ko) | 2012-08-08 | 2015-11-25 | 주식회사 씨엠지제약 | 아리피프라졸을 포함하는 경구용 속용 필름 제제 |
US9193685B2 (en) | 2012-09-19 | 2015-11-24 | Alkermes Pharma Ireland Limited | Pharmaceutical compositions having improved storage stability |
MY179191A (en) * | 2012-09-26 | 2020-10-30 | Pfizer | Apixaban liquid formulations |
US8568747B1 (en) | 2012-10-05 | 2013-10-29 | Silvergate Pharmaceuticals, Inc. | Enalapril compositions |
US20140107130A1 (en) * | 2012-10-11 | 2014-04-17 | Antrim Pharmaceuticals, LLC | Oral Solution Formulations of Aripiprazole |
WO2014060324A1 (en) | 2012-10-16 | 2014-04-24 | Sanovel Ilac Sanayi Ve Ticaret A.S | Aripiprazole formulations |
CA2891122C (en) | 2012-11-14 | 2021-07-20 | The Johns Hopkins University | Methods and compositions for treating schizophrenia |
JP6203682B2 (ja) * | 2013-07-10 | 2017-09-27 | 共和薬品工業株式会社 | アリピプラゾール含有水性液剤 |
CN103393594A (zh) * | 2013-08-22 | 2013-11-20 | 万特制药(海南)有限公司 | 一种新的阿立哌唑的制剂组合物 |
BR112016021535A8 (pt) | 2014-03-20 | 2021-07-20 | Alkermes Pharma Ireland Ltd | kit compreendendo formulações de aripiprazol tendo velocidades de injeção aumentadas útil para o tratamento de uma desordem do sistema nervoso central e uso |
WO2016189504A1 (en) * | 2015-05-28 | 2016-12-01 | Leiutis Pharmaceuticals Pvt Ltd | Non-lyophilized compositions of aripiprazole and methods of preparation thereof |
JP6039849B1 (ja) * | 2015-06-12 | 2016-12-07 | 高田製薬株式会社 | アリピプラゾール含有内用液剤 |
WO2017025930A1 (en) * | 2015-08-12 | 2017-02-16 | Ftf Pharma Private Limited | Oral solution of aripiprazole |
US9463183B1 (en) | 2015-10-30 | 2016-10-11 | Silvergate Pharmaceuticals, Inc. | Lisinopril formulations |
US9669008B1 (en) | 2016-03-18 | 2017-06-06 | Silvergate Pharmaceuticals, Inc. | Enalapril formulations |
CN108434146A (zh) * | 2017-02-16 | 2018-08-24 | 天津国际生物医药联合研究院 | 一种hiv-1整合酶抑制剂的溶液剂及其制备方法和应用 |
CN109498556A (zh) * | 2017-09-15 | 2019-03-22 | 万特制药(海南)有限公司 | 阿立哌唑口服溶液及其制备方法 |
EP3761983A1 (en) | 2018-03-05 | 2021-01-13 | Alkermes Pharma Ireland Limited | Aripiprazole dosing strategy |
CN112666267B (zh) * | 2019-10-15 | 2023-09-26 | 上海上药中西制药有限公司 | 一种阿立哌唑药品有关物质的检测方法 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU843739A3 (ru) † | 1978-02-17 | 1981-06-30 | Карл Томэ Гмбх (Фирма) | Способ получени карбостириловыхили ОКСиНдОлОВыХ пРОизВОдНыХ |
JPS54130587A (en) | 1978-03-30 | 1979-10-09 | Otsuka Pharmaceut Co Ltd | Carbostyryl derivative |
PH17194A (en) * | 1980-03-06 | 1984-06-19 | Otsuka Pharma Co Ltd | Novel carbostyril derivatives,and pharmaceutical composition containing the same |
JPS5959663A (ja) † | 1982-09-29 | 1984-04-05 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体−シクロデキストリン包接化合物 |
US5006528A (en) | 1988-10-31 | 1991-04-09 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivatives |
JP3265680B2 (ja) * | 1992-03-12 | 2002-03-11 | 大正製薬株式会社 | 経口製剤用組成物 |
US5457099A (en) † | 1992-07-02 | 1995-10-10 | Sawai Pharmaceutical Co., Ltd. | Carbostyril derivatives and antiallergic agent |
TW254855B (hu) | 1993-07-28 | 1995-08-21 | Otsuka Pharma Co Ltd | |
BR9811458A (pt) * | 1997-03-31 | 2000-09-19 | Johnson & Johnson Consumer | "sistema solvente para penetração melhorada de compostos farmacêuticos" |
US20030077227A1 (en) * | 1997-10-01 | 2003-04-24 | Dugger Harry A. | Buccal, polar and non-polar spray or capsule containing drugs for treating disorders of the central nervous system |
AU6023999A (en) * | 1998-09-03 | 2000-03-27 | Alcide Corporation | Freeze-resistant topical germicides and methods related thereto |
US20020076437A1 (en) * | 2000-04-12 | 2002-06-20 | Sanjeev Kothari | Flashmelt oral dosage formulation |
CA2311734C (en) * | 2000-04-12 | 2011-03-08 | Bristol-Myers Squibb Company | Flash-melt oral dosage formulation |
-
2002
- 2002-03-28 MY MYPI20021124A patent/MY129350A/en unknown
- 2002-04-15 AR ARP020101366A patent/AR033168A1/es unknown
- 2002-04-19 TW TW091108139A patent/TWI337865B/zh not_active IP Right Cessation
- 2002-04-24 BR BR0208986-6A patent/BR0208986A/pt active Search and Examination
- 2002-04-24 AU AU2002254722A patent/AU2002254722B2/en not_active Expired
- 2002-04-24 CZ CZ2003-2821A patent/CZ306181B6/cs not_active IP Right Cessation
- 2002-04-24 CA CA002445276A patent/CA2445276C/en not_active Expired - Fee Related
- 2002-04-24 KR KR1020037013943A patent/KR100909329B1/ko active IP Right Grant
- 2002-04-24 PL PL364666A patent/PL206882B1/pl unknown
- 2002-04-24 UA UA20031110599A patent/UA76144C2/uk unknown
- 2002-04-24 EP EP02723964A patent/EP1381367B1/en not_active Expired - Lifetime
- 2002-04-24 WO PCT/US2002/013048 patent/WO2002085366A1/en active IP Right Grant
- 2002-04-24 JP JP2002582939A patent/JP4401077B2/ja not_active Expired - Lifetime
- 2002-04-24 EE EEP200300523A patent/EE05581B1/xx not_active IP Right Cessation
- 2002-04-24 DK DK02723964.9T patent/DK1381367T3/da active
- 2002-04-24 ES ES02723964T patent/ES2377855T3/es not_active Expired - Lifetime
- 2002-04-24 AT AT02723964T patent/ATE537831T1/de active
- 2002-04-24 IL IL15820202A patent/IL158202A0/xx active IP Right Grant
- 2002-04-24 MX MXPA03009728A patent/MXPA03009728A/es active IP Right Grant
- 2002-04-24 HU HU0303946A patent/HU230456B1/hu not_active IP Right Cessation
- 2002-04-24 RU RU2003132426/15A patent/RU2295960C2/ru not_active IP Right Cessation
- 2002-04-24 SK SK1264-2003A patent/SK287948B6/sk not_active IP Right Cessation
- 2002-04-24 RS YU84703A patent/RS52082B/sr unknown
- 2002-04-24 EP EP11190103.9A patent/EP2436384B2/en not_active Expired - Lifetime
- 2002-04-24 CN CN028112148A patent/CN1512884B/zh not_active Ceased
- 2002-04-24 GE GE5332A patent/GEP20053602B/en unknown
- 2002-04-24 US US10/131,304 patent/US6977257B2/en not_active Expired - Lifetime
- 2002-04-24 NZ NZ528550A patent/NZ528550A/en not_active IP Right Cessation
- 2002-04-24 UY UY27273A patent/UY27273A1/es not_active Application Discontinuation
- 2002-04-24 PT PT02723964T patent/PT1381367E/pt unknown
- 2002-04-25 PE PE2002000346A patent/PE20021086A1/es not_active Application Discontinuation
-
2003
- 2003-10-01 IL IL158202A patent/IL158202A/en not_active IP Right Cessation
- 2003-10-01 BG BG108216A patent/BG66177B1/bg unknown
- 2003-10-06 ZA ZA200307797A patent/ZA200307797B/en unknown
- 2003-10-14 IS IS6994A patent/IS2863B/is unknown
- 2003-10-21 NO NO20034705A patent/NO324606B1/no not_active IP Right Cessation
- 2003-10-24 HR HR20030870A patent/HRP20030870B1/xx not_active IP Right Cessation
-
2004
- 2004-02-19 HK HK04101190.2A patent/HK1058316A1/xx not_active IP Right Cessation
-
2012
- 2012-03-14 CY CY20121100273T patent/CY1112606T1/el unknown
- 2012-09-28 HK HK12109608.1A patent/HK1168792A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE05581B1 (et) | Aripiprasooli ravimlahus peroraalseks manustamiseks | |
NO20033556L (no) | Farmasöytiske formuleringer | |
NO20033384L (no) | Farmasoytisk formulering | |
NO20033815D0 (no) | Farmasöytiske salter | |
EE200300416A (et) | Ravimvorm | |
NO20040125L (no) | Enterale formuleringer | |
DE50201898D1 (de) | Inhalationskapseln | |
NO20035627D0 (no) | Farmasöytisk formulering | |
NO20035315D0 (no) | Farmasöytiske kombinasjoner | |
DE50209245D1 (de) | Neuroprotektives medikament | |
NO20034556L (no) | Imidazotriazinon-holdige sammensetninger for nasal administrering | |
DE60203537D1 (de) | 5ht1-rezeptoragonist enthaltendes arzneimittel | |
NO20041485L (no) | Farmasoytisk formulering omfattende (R)-bicalutamid | |
NO20043007L (no) | Farmasoytisk suspensjon for oral administrering | |
FI20012242A0 (fi) | Uudet farmaseuttiset yhdisteet | |
NO20041236L (no) | Farmasoytisk formulering | |
DK1330280T3 (da) | Lægemiddelinhalator | |
SE0102823D0 (sv) | New drug | |
SE0103116D0 (sv) | Pharmaceutical combination | |
SE0102957D0 (sv) | Pharmaceutical formulation | |
SE0101171D0 (sv) | Pharmaceutical formulation | |
SE0102572D0 (sv) | Pharmaceutical formulation | |
SE0102069D0 (sv) | Pharmaceutical formulation | |
SE0101326D0 (sv) | Pharmaceutical formulation | |
SE0101325D0 (sv) | Pharmaceutical formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
GB1A | Change in the ownership or in the address of the owner | ||
MM4A | Lapsed by not paying the annual fees |
Effective date: 20190424 |